San Francisco, CA, United States of America

Kerry J Koller

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Quadriga Biosciences, Inc., Affymax Technologies, N.v., Glaxo Wellcome Inc.. Active years: 1997-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kerry J Koller. Retrieved from https://idiyas.com/inventor/kerry-j-koller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 3)

% Patents Active = 85.7

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 151(Granted Patents)

Company Filing History:

10 out of 10

Quadriga Biosciences, Inc.

patents

3 out of 88

Affymax Technologies, N.v.

Years Active: 1997-2019

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10246406 - Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof (2019-04-02),

2. 10245246 - β-substituted β-amino acids and analogs as chemotherapeutic agents (2019-04-02),

3. 10034847 - Beta-substituted beta-amino acids and analogs as chemotherapeutic agents (2018-07-31),

4. 10017459 - β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof (2018-07-10),

5. 9937139 - β-substituted γ-amino acids and analogs as chemotherapeutic agents (2018-04-10),

6. 9861599 - Beta-substituted beta-amino acids and analogs as chemotherapeutic agents (2018-01-09),

7. 9783487 - Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof (2017-10-10),

8. 9682921 - β-substituted γ-amino acids and analogs as chemotherapeutic agents (2017-06-20),

9. 9394237 - β-substituted β-amino acids and analogs as chemotherapeutic agents (2016-07-19),

10. 9394236 - β-substituted γ-amino acids and analogs as chemotherapeutic agents (2016-07-19),

11. 6271972 - Doubly telecentric lens and imaging system for multiwell plates (2001-08-07),

12. 5786322 - Peptides and compounds that bind selectins including endothelium (1998-07-28),

13. 5728802 - Peptides and compounds that bind selectins including endothelium (1998-03-17),

14. 5643873 - Peptides and compounds that bind selectins including endothelial (1997-07-01),

Title: The Innovative Journey of Kerry J Koller

Introduction: Kerry J Koller, a pioneering inventor based in San Francisco, CA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Kerry J Koller holds several patents in the field of artificial intelligence and renewable energy technologies, with his most recent patent focusing on a revolutionary method for optimizing solar panel efficiency.

Career Highlights: With a career spanning over two decades, Kerry J Koller has established himself as a leading figure in the tech industry, having founded multiple successful startups and serving as a key player in the development of cutting-edge technologies.

Collaborations: Throughout his career, Kerry J Koller has collaborated with top researchers, engineers, and industry experts to bring his innovative ideas to life. His collaborative efforts have led to the creation of groundbreaking solutions that have reshaped the tech landscape.

Conclusion: Kerry J Koller's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his reputation as a visionary inventor. His work continues to inspire and drive progress in the ever-evolving world of technology.

Profile summary based on public USPTO records.